compound 20 has been researched along with benzoylphenylalanyl-alanyl-proline in 1 studies
| Studies (compound 20) | Trials (compound 20) | Recent Studies (post-2010) (compound 20) | Studies (benzoylphenylalanyl-alanyl-proline) | Trials (benzoylphenylalanyl-alanyl-proline) | Recent Studies (post-2010) (benzoylphenylalanyl-alanyl-proline) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 41 | 1 | 0 |
| Protein | Taxonomy | compound 20 (IC50) | benzoylphenylalanyl-alanyl-proline (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 1.3516 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allibone, PL; Greenlee, WJ; Patchett, AA; Perlow, DS; Ulm, EH; Vassil, TC | 1 |
1 other study(ies) available for compound 20 and benzoylphenylalanyl-alanyl-proline
| Article | Year |
|---|---|
Angiotensin-converting enzyme inhibitors: synthesis and biological activity of acyl tripeptide analogues of enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Dipeptides; Enalapril; Enzyme Inhibitors; Structure-Activity Relationship | 1985 |